Finance Watch: Lykos Implements 75% Workforce Reduction After FDA Rejection
Galera’s Board Approves Liquidation, Dissolution Plan
Executive Summary
Restructuring Edition: Lykos recruited a J&J veteran to help its slimmed-down staff resubmit its MDMA-based PTSD therapy. Also, Lexicon cut its field force by 50%, or 75 jobs; Viracta cut its solid tumor program and 23% of its workforce; and Boundless Bio streamlined with moderate job cuts.